J. Joaquin

Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia

I. Bernstein, S. Raimondi, R. Ries, 2019, Clinical Cancer Research.

Leukemic mutations in the methylation‐associated genes DNMT3A and IDH2 are rare events in pediatric AML: A report from the Children's Oncology Group

S. Raimondi, S. Meshinchi, T. Alonzo, 2011, Pediatric blood & cancer.

Copy-neutral loss of heterozygosity is prevalent and a late event in the pathogenesis of FLT3/ITD AML

S. Meshinchi, D. Stirewalt, E. Pogosova-Agadjanyan, 2014, Blood Cancer Journal.

Leukemic mutations in the methylation‐associated genes DNMT3A and IDH2 are rare events in pediatric AML: A report from the Children's Oncology Group

S. Raimondi, S. Meshinchi, T. Alonzo, 2011, Pediatric blood & cancer.